Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma.
Sahoo S, Ravi Kumar RK, Nicolay B, Mohite O, Sivaraman K, Khetan V, Rishi P, Ganesan S, Subramanyan K, Raman K, Miles W, Elchuri SV.
Sahoo S, et al. Among authors: subramanyan k.
FEBS Lett. 2019 Jan;593(1):23-41. doi: 10.1002/1873-3468.13294. Epub 2018 Nov 27.
FEBS Lett. 2019.
PMID: 30417337
Free article.